American Century Companies’s Clovis Oncology, Inc. CLVS Stock Holding History

American Century Companies’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-66,266	Closed	-$1.95M	–	1375
2018 Q3	$1.95M	Sell	66,266 -244	-0.4%	-$9.45K	﹤0.01%	1025
2018 Q2	$3.02M	Sell	66,510 -427	-0.6%	-$20.8K	﹤0.01%	946
2018 Q1	$3.53M	Buy	66,937 +14,782	+28%	+$862K	﹤0.01%	907
2017 Q4	$3.55M	Sell	52,155 -18,277	-26%	-$1.28M	﹤0.01%	909
2017 Q3	$5.8M	Buy	70,432 +8,786	+14%	+$697K	0.01%	810
2017 Q2	$5.77M	Buy	61,646 +20,017	+48%	+$1.22M	0.01%	823
2017 Q1	$2.65M	Buy	+41,629	New	+$2.53M	﹤0.01%	1002
2016 Q1	–	Sell	-26,127	Closed	-$914K	–	1393
2015 Q4	$914K	Sell	26,127 -4,760	-15%	-$307K	﹤0.01%	1123
2015 Q3	$2.84M	Buy	30,887 +8,992	+41%	+$778K	﹤0.01%	970
2015 Q2	$1.92M	Sell	21,895 -301	-1%	-$25.8K	﹤0.01%	1036
2015 Q1	$1.65M	Sell	22,196 -2,688	-11%	-$190K	﹤0.01%	1071
2014 Q4	$1.39M	Sell	24,884 -279	-1%	-$14.7K	﹤0.01%	1146
2014 Q3	$1.14M	Buy	25,163 +3,650	+17%	+$152K	﹤0.01%	1154
2014 Q2	$891K	Buy	21,513 +3,993	+23%	+$206K	﹤0.01%	1240
2014 Q1	$1.21M	Buy	+17,520	New	+$1.29M	﹤0.01%	1187

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

American Century Companies's CLVS Position: Q4 2018 in Review

American Century Companies sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 66,266 shares — an estimated $1.95M sold.

American Century Companies first reported a position in CLVS in Q1 2014 and held it in 15 quarters. The position peaked at $5.8M in Q3 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

American Century Companies reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
American Century Companies sold 66,266 Clovis Oncology, Inc. shares in Q4 2018, an estimated $1.95M.
American Century Companies first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 15 quarters.
American Century Companies's Clovis Oncology, Inc. position peaked at $5.8M in Q3 2017.
165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on American Century Companies's 13F filing for Q4 2018, filed 13 Feb 2019.